FDAnews Announces: Building a World-Class Advertising and Promotion Review Program Workshop, April 27-28, 2016

Share Article

FDA marketing scrutiny no longer is limited to magazine and TV ads. Come to Chicago in April for two days of intense learning and arrive back home with a bag full of tricks and tips to keep all marketing efforts squeaky-clean.

Building a World-Class Advertising and Promotion Review Program
**Presented by PhillyCooke Consulting and FDAnews**
April 27-28, 2016 – Chicago, IL
http://www.fdanews.com/advertisingpromotion

FDA marketing scrutiny no longer is limited to magazine and TV ads. Now the agency is poking around, checking signage in tradeshow booths ... checking in on Twitter and Facebook ... and listening to the physicians and other healthcare professionals you've paid to speak or train.

The federal court ruling in Amarin (Amarin Pharma Inc., et. al v. Food and Drug Administration et. al) opens the door for drugmakers to make truthful off-label statements about their benefits. But the case raises questions about what that really means to the FDA.

Google is changing things up as well. In June it announced changes to the way search engine marketing works for prescription drugs. Marketers are no longer allowed to create their own display URL. Display URLs must contain the CompanyName.com (it must be active and owned by the company) or to the specific product website (prescription treatment, prescription device, medical device, preventative treatment, prescription contraception or prescription vaccination).

Face it: Drug- and devicemakers need help. Not with creating better ads and promotions — they already know how to do that — but for making sure promotional activities aren’t magnets for warning letters.

Come to Chicago in April for two days of intense learning. Attendees will arrive back home with a bag full of tricks and tips to keep all their marketing efforts squeaky-clean.

  • Understanding Pre-Approval Communications: Don't get on the FDA's or SEC's radar screens before your product is even approved. Learn how to properly disclose information and remain in compliance.
  • How to Maximize Disease Awareness Communications: Take away valuable tips and tricks for using disease awareness communications pre- and post-approval.
  • Hurray! You're Approved: Build the most aggressive — but compliant — campaign from first day of approval to commercial launch.
  • Assuring Your Promotions Meet FDA Off-Label Standards: Successfully navigate 4 major traps that can earn you a warning letter fast.
  • Itching To Do More With Social Media?: Discover how to get your message out there ... without crossing the line.

The workshop binder materials alone are worth the tuition cost. Checklists for promotion pre-approval and effective review, FDA documents, complete and unabridged, relevant sections of Form 2253 [CFR], PhRMA’s Principles on DTC Advertising and Principles on Interactions with Healthcare Professionals and much more!

The workshop leader is Dale Cooke, principal of PhillyCooke Consulting. Mr. Cooke’s practice specializes in helping FDA-regulated companies develop compliant promotional tactics and improve the promotional review. He is the author of Effective Review & Approval of Digital Promotional Tactics and is currently at work on a book about compliant social media usage for prescription product manufacturers.

Who Should Attend:

  • Advertising and marketing managers
  • Social media teams
  • Promotion review committee members
  • Medical affairs
  • Continuing education and tradeshow organizers
  • Regulatory compliance officers
  • PRC coordinators
  • Legal Counsel
  • Compliance
  • Executive management
  • Outside ad agencies and marketing consultants

Conference Details:
Building a World-Class Advertising and Promotion Review Program
**Presented by PhillyCooke Consulting and FDAnews**
http://www.fdanews.com/advertisingpromotion
Tuition: $1,797

Easy Ways to Register:
Online: http://www.fdanews.com/advertisingpromotion
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website